Adjuvant Nivolumab versus Placebo in Muscle-Invasive Urothelial Carcinoma
SourceThe New England Journal of Medicine, 384, 22, (2021), pp. 2102-2114
Article / Letter to editor
Display more detailsDisplay less details
The New England Journal of Medicine
SubjectAll institutes and research themes of the Radboud University Medical Center; Radboudumc 15: Urological cancers RIMLS: Radboud Institute for Molecular Life Sciences
Upload full text
Use your RU credentials (u/z-number and password) to log in with SURFconext to upload a file for processing by the repository team.